Literature DB >> 9572479

Signaling pathways mediating induction of the early response genes prostaglandin G/H synthase-2 and egr-1 by serotonin via 5-HT2A receptors.

M Goppelt-Struebe1, M Stroebel.   

Abstract

Signaling pathways responsible for serotonin (5-HT)-mediated induction of early response genes prostaglandin G/H synthase-2 (PGHS-2, cyclooxygenase-2) and egr-1 were investigated in rat mesangial cells. Gene induction by 5-HT was dependent on 5-HT2A receptors that were pertussis toxin insensitive indicating coupling to a G-protein of the Gq family. Binding of 5-HT to this receptor activates phosphatidylinositol-specific phospholipase C (PLC) and release of Ca2+ from internal stores, but this activation was not related to PGHS-2 mRNA expression. Similarly, PI-3 kinase was not involved in 5-HT signaling. Instead, inhibition of phosphatidylcholine-specific PLC interfered with PGHS-2 and egr-1 mRNA induction, suggesting this enzyme as a link between 5-HT2A receptors and protein kinase C, an essential part of 5-HT-mediated signaling. The MAP kinase pathway was identified as common signaling pathway of 5-HT or phorbol ester-induced gene expression. Increase of intracellular cAMP by forskolin or dibutyryl cAMP did not induce PGHS-2 or egr-1 mRNA expression by itself, but strongly inhibited 5-HT-mediated mRNA induction. PGHS-2 mRNA and protein induction by 5-HT was also abolished by chelation of Ca2+ ions by EGTA, suggesting involvement of Ca2+-dependent enzymes. In contrast, egr-1 mRNA expression was superinduced in the presence of EGTA. Induction of Egr-1 protein was not changed by EGTA hinting to Ca2+-sensitive posttranscriptional steps. Activation of the Gq-coupled 5-HT2A receptor thus leads to the expression of the early response genes PGHS-2 and egr-1, using common as well as differing signaling elements that allow differential regulation of the expression of these genes that are functionally related to renal hemodynamics and proliferation of mesangial cells, respectively.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572479     DOI: 10.1002/(SICI)1097-4652(199806)175:3<341::AID-JCP12>3.0.CO;2-8

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

Review 1.  5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension.

Authors:  M R MacLean; P Herve; S Eddahibi; S Adnot
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Role of Rac and Cdc42 in lysophosphatidic acid-mediated cyclo-oxygenase-2 gene expression.

Authors:  Angelika Hahn; Holger Barth; Michaela Kress; Peter R Mertens; Margarete Goppelt-Struebe
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

3.  The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells.

Authors:  M Goppelt-Struebe; S Fickel; C O Reiser
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

4.  Independent regulation of cyclo-oxygenase 2 expression by p42/44 mitogen-activated protein kinases and Ca2+/calmodulin-dependent kinase.

Authors:  M Goppelt-Struebe; A Hahn; M Stroebel; C O Reiser
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

5.  In vivo evidence for a role of protein kinase C in peripheral nociceptive processing.

Authors:  Adriano L S Souza; Fabrício A Moreira; Karine R Almeida; Caryne M Bertollo; Karina A Costa; Márcio M Coelho
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.

Authors:  Yinglin Liu; Barry L Fanburg
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-29       Impact factor: 6.914

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.